Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company OcuCure Therapeutics Inc.
DescriptionTubulin inhibitor in topical eyedrop formulation
Molecular Target Tubulin
Mechanism of ActionTubulin inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat age-related macular degeneration (AMD); Treat wet age-related macular degeneration (AMD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today